ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV (Nasdaq: ARYD) is a blank check company sponsored by ARYA Sciences Management LP, the life sciences-focused SPAC franchise that has launched multiple vehicles targeting the healthcare and biotechnology sectors. The company completed its initial public offering in 2021, representing the fourth SPAC raised under the ARYA Sciences umbrella. ARYD filed its annual report on Form 10-K with the SEC on March 31, 2022, covering fiscal year 2021, at which point the company was continuing its search for a qualifying business combination target in the life sciences industry. Sign up on SpacDesk for full filing history, deal timelines, and sponsor track-record data on ARYD and the broader ARYA Sciences SPAC family.